Clicky

  • Login
  • Register
  • Submit Your Content
  • Contact Us
Sunday, June 29, 2025
World Tribune
No Result
View All Result
  • Home
  • News
  • Business
  • Technology
  • Sports
  • Health
  • Food
Submit
  • Home
  • News
  • Business
  • Technology
  • Sports
  • Health
  • Food
No Result
View All Result
World Tribune
No Result
View All Result

Novo Nordisk partners with WeightWatchers after Hims & Hers fallout

June 27, 2025
in Health
Reading Time: 3 mins read
A A
Novo Nordisk partners with WeightWatchers after Hims & Hers fallout
0
SHARES
ShareShareShareShareShare

Novo Nordisk partners with WeightWatchers after Hims & Hers fallout

Pharma giant Novo Nordisk announced that it is collaborating with WeightWatchers to offer Wegovy through NovoCare Pharmacy, effective July 1. 

Through the partnership, WeightWatchers’ telehealth program, integrated into NovoCare Pharmacy, will enable new uninsured or self-paying patients to access Wegovy for $299 per month for one month at any dose and subsequently $499 per month after. The offer is valid from July 1 through July 31. 

Novo Nordisk says the offers will help patients “previously prescribed unapproved ‘semaglutide’ start on FDA-approved Wegovy.” 

WeightWatchers will dispense Wegovy through CenterWell Pharmacy, which handles prescription fulfillment and delivery for NovoCare Pharmacy. 

Novo Nordisk said the offer will be effective through each of its telehealth partners: Ro, LifeMD and now WeightWatchers. The same deal will also be available to patients directly through NovoCare Pharmacy. 

“We understand that how people choose to receive care is changing, and in response to that, we are collaborating with WeightWatchers to deliver more accessible care to those living with chronic obesity,” Dave Moore, executive vice president of U.S. operations of Novo Nordisk, said in a statement. 

“WeightWatchers has spent over six decades building a science-backed approach to weight management, and we see strong synergy in our shared commitment to improving long-term health outcomes. We have also been very encouraged with our existing Ro and LifeMD collaborations. We will continue to pursue and build on agreements with companies that share our values and refine initiatives that help improve access to our FDA-approved medicines for patients.”

THE LARGER TREND

Earlier this week, Novo Nordisk announced it was terminating its contract with Hims & Hers, which was announced less than two months ago, alleging the direct-to-consumer virtual care company is violating federal law by selling compounded versions of the drug at scale under the pretense of “personalization.” 

Novo Nordisk also accused Hims & Hers of using misleading marketing practices, which it claims put patient safety at risk. 

Hims & Hers responded to the allegations, writing on LinkedIn, “This is a move by a pharmaceutical giant to protect its own interests by challenging lawful, personalized compounded care. Even more troubling is the effort to conflate lawful compounders with bad actors. That’s misleading and harmful, especially for patients with complex needs.”

The company’s CEO, Andrew Dedum, wrote on X, “In recent weeks, Novo Nordisk’s commercial team increasingly pressured us to control clinical standards and steer patients to Wegovy regardless of whether it was clinically best for patients. We refuse to be strong-armed by any pharmaceutical company’s anticompetitive demands that infringe on the independent decision-making of providers and limit patient choice.” 

Novo Nordisk also partners with direct-to-consumer virtual care company Ro and publicly traded telemedicine company LifeMD to sell its weight-loss drug through the telehealth providers to cash-paying clients.

In a statement announcing the WeightWatchers partnership, the pharma giant said, “Ro and LifeMD collaborations continue based on their commitment to providing safe and effective medical treatment for patients living with chronic diseases; dialogue with other companies ongoing.”

Credit: Source link

READ ALSO

DarioHealth, GreenKey Health partner to expand sleep health program

Handspring secures $12M for virtual pediatric mental health platform

ShareTweetSendSharePin
Previous Post

The Apple Watch Series 10 is $100 off ahead of Prime Day

Next Post

The best early deals available right now, dates and everything else you need to know

Related Posts

DarioHealth, GreenKey Health partner to expand sleep health program
Health

DarioHealth, GreenKey Health partner to expand sleep health program

June 27, 2025
Handspring secures M for virtual pediatric mental health platform
Health

Handspring secures $12M for virtual pediatric mental health platform

June 27, 2025
FDA clears Sora Neuroscience’s brain mapping software
Health

FDA clears Sora Neuroscience’s brain mapping software

June 27, 2025
Former Current Health CEO buys back company from Best Buy
Health

Former Current Health CEO buys back company from Best Buy

June 27, 2025
Mandolin raises M for AI automation for specialty drugs
Health

Mandolin raises $40M for AI automation for specialty drugs

June 27, 2025
Certify raises  million for increased market penetration
Health

Certify raises $40 million for increased market penetration

June 26, 2025
Next Post
The best early deals available right now, dates and everything else you need to know

The best early deals available right now, dates and everything else you need to know

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

What's New Here!

Trump administration moves to count crypto as a federal mortgage asset

Trump administration moves to count crypto as a federal mortgage asset

June 26, 2025
Snowflake to buy database startup Crunchy Data for about 0 million

Snowflake to buy database startup Crunchy Data for about $250 million

June 3, 2025
Merab Dvalishvili, Kayla Harrison dominate in title wins

Merab Dvalishvili, Kayla Harrison dominate in title wins

June 8, 2025
Dentist Matt Vogt living out impossible US Open dream

Dentist Matt Vogt living out impossible US Open dream

June 10, 2025
MLB’s decision to reinstate Pete Rose was ‘overdue’

MLB’s decision to reinstate Pete Rose was ‘overdue’

May 30, 2025
These 5 toxic phrases make kids not want to listen—say this instead

These 5 toxic phrases make kids not want to listen—say this instead

June 22, 2025
Nvidia notches 5-day win streak as it hits record highs

Nvidia notches 5-day win streak as it hits record highs

June 28, 2025

About

World Tribune is an online news portal that shares the latest news on world, business, health, tech, sports, and related topics.

Follow us

Recent Posts

  • Republicans face a possible make-or-break moment as Senate eyes key vote on Trump’s tax bill
  • Tesla first driverless delivery new car to customer
  • The horse race tragedy that united a family in heartbreak
  • Chief Justice Roberts warns against elected officials’ heated political words about judges

Newslatter

Loading
  • Submit Your Content
  • Contact Us
  • Privacy Policy
  • Terms of Use
  • DMCA

© 2024 World Tribune - All Rights Reserved!

No Result
View All Result
  • Home
  • News
  • Business
  • Technology
  • Sports
  • Health
  • Food

© 2024 World Tribune - All Rights Reserved!

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In